Question

Difficulty: EasyBreast and Endocrine Surgery

A 55-year-old woman presents to the clinic after discovering a firm, painless lump in her right breast 2 weeks ago. Physical examination reveals a 2.5-cm hard, irregular, and relatively fixed mass in the upper outer quadrant of the right breast. There is no nipple discharge, skin dimpling, or palpable axillary lymphadenopathy. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for this patient.

  1. 1Diagnostic mammography and targeted breast ultrasound
  2. 2Image-guided core needle biopsy of the mass
  3. 3Pathologic evaluation for estrogen, progesterone, and HER2 receptor status
  4. 4Breast-conserving surgery with sentinel lymph node biopsy

Answer

The correct chronological sequence is: diagnostic imaging, followed by core needle biopsy, followed by pathologic receptor testing, and finally definitive surgical excision.
The standard of care for a suspicious palpable breast mass in a woman over 30 dictates a stepwise approach. Non-invasive imaging (mammography and ultrasound) is performed first to characterize the extent of the disease. This is followed by a minimally invasive core needle biopsy to confirm malignancy. Once cancer is confirmed, the tissue is tested for receptor status to guide systemic therapy. Finally, definitive local surgical management (such as lumpectomy and sentinel lymph node biopsy) is executed.

Step-by-Step Solution

1
Identify the initial diagnostic requirement for a palpable breast mass in a patient over 30 years of age.
Diagnostic mammography and ultrasound are indicated.
Imaging characterizes the primary lesion, assesses its extent, and screens for multifocal or contralateral disease prior to any invasive intervention.
2
Determine the necessary procedure to confirm a diagnosis after suspicious imaging findings.
Core needle biopsy is performed.
A definitive histologic tissue diagnosis must be established before proceeding with definitive surgical or oncologic treatment.
3
Determine the necessary pathologic testing on the confirmed cancer specimen.
Receptor status (ER, PR, HER2) is evaluated.
The tumor's receptor profile is crucial for accurate staging and determining the need for neoadjuvant or adjuvant systemic therapies.
4
Determine the definitive local management for early-stage localized breast cancer.
Breast-conserving surgery with sentinel lymph node biopsy is planned.
Once the diagnosis and tumor biology are fully characterized, surgical resection with axillary staging provides definitive local control.

Key Concept

Algorithm for the evaluation and management of a new palpable breast mass
Rate this question